Icon Wealth Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Icon Wealth Partners’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$361K	Hold	4,944	–	–	0.04%	211
2023 Q2	$411K	Sell	4,944 -1,500	-23%	-$125K	0.04%	213
2023 Q1	$491K	Buy	+6,444	New	+$535K	0.05%	194
2022 Q2	$757K	Buy	10,194 +1,400	+16%	+$105K	0.09%	163
2022 Q1	$790K	Buy	8,794 +5,024	+133%	+$464K	0.08%	168
2021 Q4	$422K	Buy	+3,770	New	+$455K	0.04%	225

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Icon Wealth Partners's XBI Position: Q3 2023 in Review

Icon Wealth Partners held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2023 at 4,944 shares worth $361K. The position accounts for 0.04% of the portfolio, ranked #211.

Icon Wealth Partners first reported a position in XBI in Q4 2021 and has held it in 6 quarters since. The position peaked at $790K in Q1 2022. 679 funds tracked by Wall St. Rank hold XBI as of Q3 2023.

Icon Wealth Partners held 4,944 shares of State Street SPDR S&P Biotech ETF worth $361K as of Q3 2023.
Icon Wealth Partners left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2023.
State Street SPDR S&P Biotech ETF made up 0.04% of Icon Wealth Partners's portfolio in Q3 2023, its #211 holding.
Icon Wealth Partners first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 6 quarters since.
Icon Wealth Partners's State Street SPDR S&P Biotech ETF position peaked at $790K in Q1 2022.
679 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2023.

Based on Icon Wealth Partners's 13F filing for Q3 2023, filed 14 Nov 2023.